Brief: Eurocine Vaccines: vaccine candidate Immunose FLU shows good safety in clinical study

Nidhogg Resources Holding AB (publ)

21/02/2017 15:02

Feb 21 (Reuters) - Eurocine Vaccines AB  EUCI.ST : 
    * Immunose FLU, a quadrivalent influenza vaccine candidate 
showed good safety in a clinical phase I/II study 
    * Immunological results from the study are expected in Q3 
2017 
 
     
 Source text: http://bit.ly/2kV92wP 
     
 Further company coverage:  EUCI.ST   
    
 
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))